We are live on ! Find out more
GWM

Geneos Wealth Management Portfolio holdings

AUM $4.9B
1-Year Est. Return 23.65%
This Fund
S&P 500
This Quarter Est. Return
-0.95%
1 Year Est. Return
+23.65%
3 Year Est. Return
+66.72%
5 Year Est. Return
+71.27%
10 Year Est. Return
+298.51%
AUM
$2.61B
AUM Growth
+$46.3M
Cap. Flow
+$79.5M
Cap. Flow %
3.04%
Top 10 Hldgs %
18.89%
Holding
2,951
New
108
Increased
848
Reduced
537
Closed
120

Sector Composition

Rank Sector Weight
1 Technology 8.27%
2 Financials 5.92%
3 Consumer Discretionary 5.43%
4 Healthcare 4.85%
5 Industrials 3.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VTHR icon
1526
Vanguard Russell 3000 ETF
VTHR
$4.85B
$47K ﹤0.01%
238
WPP icon
1527
WPP
WPP
$5.94B
$47K ﹤0.01%
692
+1
+0.1% +$67
WTV icon
1528
WisdomTree US Value Fund
WTV
$3.36B
$47K ﹤0.01%
800
TVRD
1529
Tvardi Therapeutics
TVRD
$23.4M
$47K ﹤0.01%
86
-11
-11% -$5.52K
ARAV
1530
DELISTED
Aravive, Inc. Common Stock
ARAV
$47K ﹤0.01%
12,810
+7,200
+128% +$30.7K
PTR
1531
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
$47K ﹤0.01%
1,000
AEO icon
1532
American Eagle Outfitters
AEO
$3.01B
$46K ﹤0.01%
1,782
+1,282
+256% +$40.7K
AGGY icon
1533
WisdomTree Yield Enhanced US Aggregate Bond Fund
AGGY
$926M
$46K ﹤0.01%
900
AIG icon
1534
American International
AIG
$41.3B
$46K ﹤0.01%
838
-150
-15% -$7.73K
CCK icon
1535
Crown Holdings
CCK
$13.1B
$46K ﹤0.01%
460
L icon
1536
Loews
L
$23.6B
$46K ﹤0.01%
845
PFM icon
1537
Invesco Dividend Achievers ETF
PFM
$808M
$46K ﹤0.01%
1,290
TPVG icon
1538
TriplePoint Venture Growth BDC
TPVG
$211M
$46K ﹤0.01%
2,898
+375
+15% +$5.87K
AUPH icon
1539
Aurinia Pharmaceuticals
AUPH
$2.11B
$45K ﹤0.01%
2,108
+1,850
+717% +$29.4K
ESGE icon
1540
iShares ESG Aware MSCI EM ETF
ESGE
$6.73B
$45K ﹤0.01%
1,096
-47
-4% -$2.01K
FDD icon
1541
First Trust STOXX European Select Dividend Income Fund
FDD
$908M
$45K ﹤0.01%
3,281
-1,739
-35% -$25.4K
IPO icon
1542
Renaissance IPO ETF
IPO
$161M
$45K ﹤0.01%
715
LITE icon
1543
Lumentum
LITE
$69.3B
$45K ﹤0.01%
533
VEEV icon
1544
Veeva Systems
VEEV
$37.4B
$45K ﹤0.01%
158
VLT icon
1545
Invesco High Income Trust II
VLT
$65.7M
$45K ﹤0.01%
3,144
+145
+5% +$2.16K
AGR
1546
DELISTED
Avangrid, Inc.
AGR
$45K ﹤0.01%
940
+414
+79% +$21.8K
ARNC
1547
DELISTED
Arconic Corporation
ARNC
$45K ﹤0.01%
1,391
BKMC icon
1548
BNY Mellon US Mid Cap Core Equity ETF
BKMC
$671M
$44K ﹤0.01%
1,500
BXP icon
1549
Boston Properties
BXP
$11.1B
$44K ﹤0.01%
395
MSM icon
1550
MSC Industrial Direct
MSM
$6.86B
$44K ﹤0.01%
550
+100
+22% +$8.49K

Similar funds

Geneos Wealth Management's Q3 2021 Portfolio in Review

As of Q3 2021, Geneos Wealth Management held 2,951 positions worth $2.61B, up 1.8% from $2.56B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Geneos Wealth Management deployed $79.5M of net new capital in Q3 2021, opening 108 new positions and adding to 848 existing holdings. Its largest new stake was ProShares Ultra Semiconductors: 2,223,832 shares worth $19.1M.

By sector, the portfolio is most concentrated in Technology at 8.3% of assets, up from 8.2% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was iShares Short Maturity Bond ETF, an estimated $27.3M trimmed.

  • Geneos Wealth Management's largest Q3 2021 buy was ProShares Ultra Semiconductors: 2,223,832 shares worth $19.1M.
  • Geneos Wealth Management added most to iShares Core 1-5 Year USD Bond ETF in Q3 2021, an estimated $22.6M increase.
  • Geneos Wealth Management's biggest Q3 2021 reduction was iShares Short Maturity Bond ETF, cutting an estimated $27.3M.
  • Geneos Wealth Management fully exited ProShares Ultra Energy in Q3 2021, selling an estimated $21M.
  • Geneos Wealth Management's ten largest holdings make up 19% of its $2.61B portfolio in Q3 2021.
  • Geneos Wealth Management opened 108 new positions and closed 120 in Q3 2021.
  • Geneos Wealth Management's portfolio value rose 1.8% quarter-over-quarter to $2.61B.

Based on Geneos Wealth Management's 13F filing for Q3 2021, filed 9 Nov 2021.